Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence.

Nature medicine·2026
Same author

Prognostic factor research: why it matters in orthopaedics and how we do it better.

Bone & joint open·2026
Same author

Cost-effectiveness of osteoporotic fracture risk assessment in people with intellectual disabilities: a UK NHS modelling study.

BMJ open·2026
Same author

Substantial international variation in the cost of blood group and save and crossmatch: A systematic review.

British journal of haematology·2026
Same author

Effectiveness of drug interventions to prevent delirium after surgery for older adults: systematic review and network meta-analysis of randomised controlled trials.

BMJ (Clinical research ed.)·2026
Same author

Reporting Completeness of Systematic Reviews of Nutrition or Diet-Related Randomised Controlled Trials: A Meta-Research on Adherence to PRISMA Items.

Nutrition reviews·2026

Related Experiment Video

Updated: Jan 15, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

489

Clinical prediction models using machine learning in oncology: challenges and recommendations.

Gary S Collins1, Mae Chester-Jones2, Stephen Gerry2

  • 1Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.

BMJ Oncology
|October 10, 2025
PubMed
Summary

Developing robust clinical prediction models in oncology requires careful attention to methodology and implementation. Addressing data challenges, ensuring fairness, and evaluating clinical utility are crucial for translating these tools into practice.

Keywords:
Epidemiology

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Jan 15, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

489
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Oncology
  • Biostatistics
  • Health Informatics

Background:

  • Clinical prediction models are vital in oncology for personalized diagnosis and prognosis.
  • Machine learning is increasingly used, but methodological flaws hinder implementation.

Purpose of the Study:

  • To outline key considerations for developing robust and equitable cancer prediction models.
  • To identify challenges in model development, evaluation, and implementation.

Main Methods:

  • Review of critical steps: systematic reviews, protocol development, registration, end-user engagement, sample size, and data representativeness.
  • Addressing technical challenges: missing data, fairness, complex data structures (censoring, competing risks, clustering).
  • Comprehensive evaluation: statistical performance (discrimination, calibration) and clinical utility.

Main Results:

  • Most cancer prediction models remain unimplemented due to methodological and translational challenges.
  • Barriers include limited stakeholder engagement, insufficient clinical utility evidence, workflow integration issues, and lack of post-deployment monitoring.

Conclusions:

  • Addressing development-to-practice gaps requires attention from study design to post-implementation monitoring.
  • Developing trustworthy tools is essential for realizing the potential of personalized cancer care.